Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- Author
- SANDBORN, William J1 ; FEAGAN, Brian G2 ; FOX, Irving11 ; ROSARIO, Maria11 ; SANKOH, Serap11 ; JING XU11 ; STEPHENS, Kristin11 ; MILCH, Catherine11 ; PARIKH, Asit11 ; RUTGEERTS, Paul5 ; HANAUER, Stephen6 ; COLOMBEL, Jean-Frédéric7 8 ; SANDS, Bruce E8 ; LUKAS, Milan9 ; FEDORAK, Richard N3 ; LEE, Scott10 ; BRESSLER, Brian4
[1] University of California, San Diego, La Jolla, United States
[2] Robarts Clinical Trials, Robarts Research Institute, and the Departments of Medicine and of Epidemiology and Biostatistics, University of Western Ontario, London, Canada
[3] University of Alberta, Edmonton, Canada
[4] University of British Columbia, Vancouver, Canada
[5] Katholieke Universiteit and University Hospital Gasthuisberg, Leuven, Belgium
[6] University of Chicago, Chicago, United States
[7] Département d'Hépato-gastroentérologie et Centre d'Investigations Cliniques, Centre Hospitalier Régional Universitaire de Lille, Université Lille Nord de France, Lille, France
[8] Icahn School of Medicine at Mount Sinai, New York, United States
[9] General Faculty Hospital, Prague, Czech Republic
[10] University of Washington, Seattle, United States
[11] Millennium Pharmaceuticals, Cambridge, MA, United States
GEMINI 2 Study Group - Source
The New England journal of medicine. 2013, Vol 369, Num 8, pp 711-721, 11 p ; ref : 38 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Chimiothérapie Entérite de Crohn Médecine Traitement entretien Traitement induction Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin Traitement
- Keyword (en)
- Chemotherapy Crohn disease Medicine Maintenance treatment Induction treatment Inflammatory disease Digestive diseases Intestinal disease Treatment
- Keyword (es)
- Quimioterapia Enteritis Crohn Medicina Tratamiento sostén Tratamiento inductivo Enfermedad inflamatoria Aparato digestivo patología Intestino patología Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27623244
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1215739 
https://dx.doi.org/10.1056/NEJMoa1215739
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1215739\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"721\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"FEAGAN, Brian G\";i:1;s:11:\"FOX, Irving\";i:2;s:14:\"ROSARIO, Maria\";i:3;s:13:\"SANKOH, Serap\";i:4;s:7:\"JING XU\";i:5;s:17:\"STEPHENS, Kristin\";i:6;s:16:\"MILCH, Catherine\";i:7;s:12:\"PARIKH, Asit\";i:8;s:15:\"RUTGEERTS, Paul\";i:9;s:16:\"HANAUER, Stephen\";i:10;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:11;s:14:\"SANDS, Bruce E\";i:12;s:12:\"LUKAS, Milan\";i:13;s:18:\"FEDORAK, Richard N\";i:14;s:10:\"LEE, Scott\";i:15;s:15:\"BRESSLER, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1215739\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"721\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"FEAGAN, Brian G\";i:1;s:11:\"FOX, Irving\";i:2;s:14:\"ROSARIO, Maria\";i:3;s:13:\"SANKOH, Serap\";i:4;s:7:\"JING XU\";i:5;s:17:\"STEPHENS, Kristin\";i:6;s:16:\"MILCH, Catherine\";i:7;s:12:\"PARIKH, Asit\";i:8;s:15:\"RUTGEERTS, Paul\";i:9;s:16:\"HANAUER, Stephen\";i:10;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:11;s:14:\"SANDS, Bruce E\";i:12;s:12:\"LUKAS, Milan\";i:13;s:18:\"FEDORAK, Richard N\";i:14;s:10:\"LEE, Scott\";i:15;s:15:\"BRESSLER, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1215739\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1215739\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"721\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"FEAGAN, Brian G\";i:1;s:11:\"FOX, Irving\";i:2;s:14:\"ROSARIO, Maria\";i:3;s:13:\"SANKOH, Serap\";i:4;s:7:\"JING XU\";i:5;s:17:\"STEPHENS, Kristin\";i:6;s:16:\"MILCH, Catherine\";i:7;s:12:\"PARIKH, Asit\";i:8;s:15:\"RUTGEERTS, Paul\";i:9;s:16:\"HANAUER, Stephen\";i:10;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:11;s:14:\"SANDS, Bruce E\";i:12;s:12:\"LUKAS, Milan\";i:13;s:18:\"FEDORAK, Richard N\";i:14;s:10:\"LEE, Scott\";i:15;s:15:\"BRESSLER, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1215739\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"721\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"FEAGAN, Brian G\";i:1;s:11:\"FOX, Irving\";i:2;s:14:\"ROSARIO, Maria\";i:3;s:13:\"SANKOH, Serap\";i:4;s:7:\"JING XU\";i:5;s:17:\"STEPHENS, Kristin\";i:6;s:16:\"MILCH, Catherine\";i:7;s:12:\"PARIKH, Asit\";i:8;s:15:\"RUTGEERTS, Paul\";i:9;s:16:\"HANAUER, Stephen\";i:10;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:11;s:14:\"SANDS, Bruce E\";i:12;s:12:\"LUKAS, Milan\";i:13;s:18:\"FEDORAK, Richard N\";i:14;s:10:\"LEE, Scott\";i:15;s:15:\"BRESSLER, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1215739\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"721\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"FEAGAN, Brian G\";i:1;s:11:\"FOX, Irving\";i:2;s:14:\"ROSARIO, Maria\";i:3;s:13:\"SANKOH, Serap\";i:4;s:7:\"JING XU\";i:5;s:17:\"STEPHENS, Kristin\";i:6;s:16:\"MILCH, Catherine\";i:7;s:12:\"PARIKH, Asit\";i:8;s:15:\"RUTGEERTS, Paul\";i:9;s:16:\"HANAUER, Stephen\";i:10;s:25:\"COLOMBEL, Jean-Fr\u00e9d\u00e9ric\";i:11;s:14:\"SANDS, Bruce E\";i:12;s:12:\"LUKAS, Milan\";i:13;s:18:\"FEDORAK, Richard N\";i:14;s:10:\"LEE, Scott\";i:15;s:15:\"BRESSLER, Brian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
